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Purpose: Significant interest has emerged in the design of cell scaffolds that incorporate peptide sequences that correspond 
to known signaling domains in extracellular matrix and bone morphogenetic protein. The purpose of this study was to evalu-
ate the bone regenerative effects of the synthetic peptide in a critical-size rat calvarial defect model.
Methods: Eight millimeter diameter standardized, circular, transosseus defects created on the cranium of forty rats were im-
planted with synthetic peptide, collagen, or both synthetic peptide and collagen. No material was was implanted the control 
group. The healing of each group was evaluated histologically and histomorphometrically after 2- and 8-week healing inter-
vals.
Results: Surgical implantation of the synthetic peptide and collagen resulted in enhanced local bone formation at both 2 and 
8 weeks compared to the control group. When the experimental groups were compared to each other, they showed a similar 
pattern of bone formation. The defect closure and new bone area were significantly different in synthetic peptide and colla-
gen group at 8 weeks.
Conclusions: Concerning the advantages of biomaterials, synthetic peptide can be an effective biomaterial for damaged 
periodontal regeneration.
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INTRODUCTION
The ultimate reason for periodontal treatment is to regen-
erate the periodontal tissue loss caused by periodontal dis-
ease [1-3]. Periodontal regeneration is the healing pattern of 
new attachment, new bone formation, new cementum and 
new periodontal ligament. Many approaches are available for 
regenerating periodontal tissue, including root conditioning, 
which enhances cell adhesive capacity, bone grafts used for 
bony defect regeneration, and guided bone regeneration us-
ing specific cell migration and bone morphorgenetic protein 
(BMP) [4] and various other growth factors [5]. BMPs are mem-
bers of the transforming growth factor-b (TGF-b) superfami-
ly, in which the cytokines induce ectopic bone formation [4,6,7]. 
Among the BMPs, rh-BMP-2, and -7 [8], which have been syn-
thesized by the DNA technique, are known to have the best 
osteoconduction. In one study, a composite of gelatin and 
rhBMP-2 released rhBMP-2 in the proper way and also dem-
onstrated the largest amount of bone formation [9].
BMPs need to be directed to the exact location where bone 
repair is needed. Recently, there have been studies on the pro-
tein transduction domain, which can transmit protein that is 
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difficult to effectively penetrate intracellularly [10]. The phe-
nomenon of the penetration of peptide has shown the possi-
bility of the therapeutic effect of a fast half-life for its fast pen-
etration intracelluarly. Peptides consist of a specific amino 
acid sequence that can penetrate the cell membrane sponta-
neously [11,12]. Peptides are short polymers formed from link-
ing a-amino acids in a defined order. The link between one 
amino acid residue and the next is known as an amide bond 
or peptide bond. Proteins are polypeptide molecules (or con-
sist of multiple polypeptide subunits). The distinction is that 
peptides are short and polypeptides or proteins are long.
In this regard, synthetic peptide has been developed with 
the interest of developing an osteoconductive biomaterial. 
Significant interest has emerged in the design of cell scaf-
folds that incorporate peptide sequences that correspond to 
known signaling domains in extracellular matrix (ECM) pro-
teins [13]. Peptides offer the advantages of increased stability, 
the ability to incorporate them at much higher concentra-
tions than full proteins, and relatively straightforward and 
simple syntheses of short sequences [13]. Synthetic peptide 
was based on BMP-2, which promotes the formation and re-
generation of bone and cartilage, and also participates in or-
ganogenesis, cell differentiation, cell proliferation, and apop-
tosis [4].
This synthetic peptide was developed for its various advan-
tages when compared with BMP-2. It is more economical in 
that the raw material is cheaper than BMP-2. It is very stable 
in terms of temperature storage. Peptides are known to de-
naturize at room temperature. However, the sequence is short 
in the synthetic peptide. It can be stored in a freeze-dried con-
dition for over 2 years. It can also be stored at room tempera-
ture in a dry environment, whereas BMP-2 is a cold chain that 
can only be stored for a short time, for example, 6 months at 
4°C.
On this basis, the purpose of this study was to evaluate the 
effects of bone regeneration of synthetic peptide in surgical-
ly created rat calvarial defects.
MATERIALS AND METHODS
Animals
Forty male Sprague-Dawley rats (body weight, 200 to 300 g) 
were used in this study. Animal selection and management, 
surgical protocol, and preparation followed the routines ap-
proved by the Institutional Animal Care and Use Committee 
of Yonsei Medical Center in Seoul, Korea.
Experimental group design
The animals were divided into four groups of 10 animals 
each and allowed to heal for 2 weeks (5 rats) or 8 weeks (5 rats) 
as shown in Table 1. Each animal was categorized as either 
one of four groups: a sham-surgery control group in which 
no material was applied to the defect, collagen carrier alone 
group, synthetic peptide alone group, or both synthetic pep-
tide in collagen carrier group.
Designing of the synthetic peptide
The significant amino acid sequences in growth factors and 
ECM, both of which are involved in bone formation, the ear-
ly attachment, proliferation, and differentiation of the osteo-
cyte, were analyzed among the whole amino acid sequence 
of the following proteins; BMP-2, fibronectin, and vitronec-
tin. In the case of BMP-2, bone forming cells, i.e., osteoblasts, 
have a specific binding site and in terms of the ECM, consid-
ering that the sequence is involved in cell attachment, the 
synthetic peptide was recombined based on the sequence. 
The osteoblasts can recognize the sequence of synthetic pep-
tide as an active domain of the protein, so synthetic peptide 
was recombined to induce attachment, proliferation, and dif-
ferentiation. N- and C-terminals were stabilized through ami-
dation, and acetylation. Of all the amino acid sequences of 
BMP-2, fibronectin and vitronectin, the amino acid sequence 
that plays the core role in the proliferation and differentia-
tion of osteoblasts was selected and analyzed. A part of these 
sequences was modified by peptide synthesizer and the syn-
thetic peptide was formed. The final product after synthesis 
was purified to a level over 95% using high pressure liquid 
chromatography and the mass was analyzed through nuclear 
magnetic resonance. The synthesis and purification of syn-
thetic peptide was consulted with Shimadzu Co., Ltd. A Prom-
inence HPLC (Shimadazu Co., Kyoto, Japan) was used to de-
termine the flow rate, which was 1.0 mL/min and the detec-
tion was performed at 220 nm and was purified at 98.6%. The 
concentration of the synthetic peptide was loaded with 10 µL 
(mass: 2,288) (application number: 10-2008-54730 [08.6.11], reg-
istration number: 10-879704 [09.1.13]).
Surgical protocol
The animals were anaesthetized by an intramuscular injec-
tion (5 mg/kg body weight.) consisting of ketamine hydrochlo-
ride (KetalarTM, Yuhan Co., Seoul, Korea). Routine infiltration 
Table 1. Experimental groups.
Groups Two weeks Eight weeks
Control 5 5
Collagen alone 5 5
Synthetic peptide alone 5 5
Synthetic peptide in collagen carrier 5 5
Total (n=40) 20 20
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anaesthesia with 2% lidocaine and 1:100,000 epinephrine 
(Kwangmyung Pharm., Seoul, Korea) was used at the surgical 
site. An incision was made in the sagittal plane across the cra-
nium and a full thickness flap was reflected, exposing the cal-
varial bone. A standardized, circular, transosseous defect, 8 
mm in diameter, was created on the cranium with the use of 
a saline-cooled trephine drill (Biomet 3i, Palm Beach Gardens, 
USA). After removal of the trephined calvarial disk, absorbable 
collagen membrane 1 cm × 1 cm (CollatapeTM, Integra Life-
Sciences Co., Plainsboro, USA), the carrier and synthetic pep-
tide were applied to the defects. The animals were divided 
into four groups of 10 animals each and allowed to heal for 2 
(5 rats) and 8 (5 rats) weeks. Each animal received one of three 
experimental conditions: synthetic peptide only, collagen only, 
or both synthetic peptide and collagen. The periosteum and 
skin were then closed and sutured with 4-0 Monosyn (Aescu-
lap Inc., Center Valley, USA).
Evaluation methods
Clinical findings
Wound healing was generally observed to be uneventful.
Specimen preparation
The animals were sacrificed by CO2 asphyxiation at 2 or 8 
weeks post-surgery. Block sections including the experimen-
tal sites were removed. Samples were fixed in 10% neutral 
buffered formalin solution for 10 days. Samples were decalci-
fied in 5% formic acid for 14 days and embedded in paraffin. 
Serial sections, 5 µm thick, were prepared at intervals of 80 µm, 
stained with Hematoxylin/Eosin and examined using a light 
microscope. The most central sections from each block were 
selected to compare histologic findings among the groups.
Histomorphometric analysis
Computer-assisted histometric measurements were obtained 
using an automated image analysis system (Image-Pro Plus®, 
Media Cybernetics, Silver Spring, USA) coupled with a video 
camera on a light microscope (Olympus BX50TM, Olympus 
Optical Co., Tokyo, Japan). Sections were examined at 20× 
magnification. A digitizer was used to trace the defect out-
line versus new bone formation, and a percentage of bone 
fill was determined. The following histomorphometric pa-
rameters were measured from each sample (Fig. 1):
Defect closure (%): the distance (at each side of the defect) • 
between the defect margin and the in-growing bone mar-
gin in millimeters × 100.
New bone area (mm• 2): all tissues within the boundaries 
of newly formed bone, i.e., mineralized bone and fatty mar-
row and fibrovascular tissue / marrow and residual bio-
material.
Bone density (%): the newly formed bone within the new • 
bone area in millimeters × 100.
Statistical analysis
Histomorphometric recordings from the samples were used 
to calculate means and standard deviations (mean ± SD). To 
analyze the effect of both time and condition and to detect 
the interaction effect between time and condition, two-way 
analysis of variance was used (P < 0.05). ANOVA and a Post hoc 
test were used to analyze the differences among the groups 
at each point in time (P < 0.05). For the comparison between 2 
and 8 weeks in the same group, statistical significance was 
determined by a paired t-test (P < 0.05).
RESULTS
Clinical observations
Wound healing was generally uneventful and appeared sim-
ilar for the experimental groups. Material exposure or other 




At 2 weeks post-surgery, the defect was filled with thin, loose 
connective tissue. The control group showed minimal new 
bone formation originating from the defect margins (Fig. 2).
Eight weeks
At 8 weeks post-surgery, there was a relatively consistent 
density of connective tissue around minimal new bone for-
mation. However, loose connective tissue could still be ob-
served. The bone forming cells, osteoblasts, were observed at 




New bone = n
Biomaterials = m
Fatty marrow = M
Defect closure (%) = (a - b) / a × 100
New bone area = n + m + M
Bone density (%) = n / (n + b + M) × 100
Figure 1. Schematic drawings of calvarial osteotomy defect show-
ing histomorphometric analysis.
Journal of Periodontal
& Implant ScienceJPISSynthetic peptide with collagen enhanced bone formation14
Collagen alone group
Two weeks
The defects were filled with loose or dense, fibrous connec-
tive tissue and limited new bone formation was observed at 
the defect margin at 2 weeks. Collagen remained in the sub-
epithelium, there was no resorption, and it maintained the ex-
ternal form and was surrounded by connective tissue (Fig. 4).
Eight weeks
The resorption of the collagen progressed greatly. There 
was almost no infiltration of inflammatory cells. There was 
an increase in bone volume and there was no invagination 
of the peripheral tissue (Fig. 5).
Synthetic peptide alone group
Two weeks
There was almost no resorption and there was slightly new 
bone formation and a slight increase in volume as well. There 
was not much defect closure yet at 2 weeks. The margin was 
differentiated from the peripheral tissue (Fig. 6).
Eight weeks
There was a great amount of resorption. The new bone for-
mation increased compared to the 2 weeks’ group. There was 
resorption; however, the exterior was roughly maintained. 
There was a greater closure compared to the 2-week group. 
Figure 3. Control group at 8 weeks (H&E stain, ×20) representative 
photomicrographs of defect sites receiving control at 8 weeks post-
surgery. At 8 weeks, more bone formation was observed in the base 
when compared to 2 weeks.
Figure 2. Control group at 2 weeks (H&E stain, ×20) representative 
photomicrographs of defect sites receiving control at 2 weeks post-
surgery. At 2 weeks, the augmented area was covered with dense con-
nective tissue. Minimal new bone formation was observed.
Figure 5. Collagen alone group at 8 weeks (H&E stain, ×20) repre-
sentative photomicrographs of defect sites receiving collagen only 
at 8 weeks post-surgery. The resorption of collagen progressed ex-
tensively. There was an increase in bone volume and there was no 
invagination of the peripheral tissue.
Figure 4. Collagen alone group 2 weeks (H&E stain, ×20) represen-
tative photomicrographs of defect sites receiving collagen only at 2 
weeks post-surgery. The defects were filled with loose or dense, fi-
brous connective tissue and limited new bone formation was ob-
served at the defect margin at 2 weeks.
Journal of Periodontal
& Implant ScienceJPIS Jung-Yoo Choi et al. 15
Osteoblast-like cells and a very few giant multinucleated cells 
could be detected in the periphery of the margin whereas 
the center showed almost no new bone formation (Fig. 7).
Synthetic peptide in collagen carrier group
Two weeks
There was little bone regeneration or defect closure. The re-
sorption had not yet progressed and the volume was main-
tained. No osteoblast-like cells were detected (Figs. 8 and 9).
Eight weeks
At 8 weeks post-surgery, new bone formation was enhanced. 
There was loose connective tissue formation around the de-
fect area and there was no infiltration of inflammatory cells. 
Collagen was almost resorbed. The defect area was replaced 
by a parallel pattern of connective tissue (Figs. 10 and 11).
Histomorphometric analysis
The results of the histomorphometric analysis are shown 
in Tables 2-4. There was minimal new bone formation in the 
control group. At all time points, defect closure and new bone 
in all experimental groups were significantly different from 
that in the control group (P < 0.05).
Figure 7. Synthetic peptide alone group at 8 weeks (H&E stain, ×20) 
representative photomicrographs of defect sites receiving synthetic 
peptide only at 8 weeks post-surgery. There was a great deal of re-
sorption. The new bone formation increased compared to the 2-week 
group. Osteoblast-like cells and a very few giant multinucleated cells 
could be detected in the periphery of the margin whereas the center 
showed almost no new bone formation.
Figure 6. Synthetic peptide alone group at 2 weeks (H&E stain, ×20) 
representative photomicrographs of defect sites receiving synthetic 
peptide only at 2 weeks post-surgery. There was almost no resorption 
and there was slight new bone formation, a slight increase in volume 
as well.
NB
Figure 9. Synthetic peptide in collagen carrier group at 2 weeks (H&E 
stain, ×50) representative photomicrographs of defect sites receiving 
synthetic peptide and collagen only at 2 weeks post-surgery. There 
were no osteoblast-like cells detected.
Figure 8. Synthetic peptide in collagen carrier group at 2 weeks (H&E 
stain, ×20) representative photomicrographs of defect sites receiving 
synthetic peptide and collagen only at 2 weeks post-surgery. There 
was not much bone regeneration or defect closure.
Journal of Periodontal
& Implant ScienceJPISSynthetic peptide with collagen enhanced bone formation16
At 8 weeks, the collagen group showed a significantly great-
er defect closure and new bone area than the synthetic pep-
tide group (P < 0.01). There were statistically significant dif-
ferences between the results obtained at 2 and 8 weeks in the 
collagen group (P < 0.05). There was no significant bone growth 
in the synthetic peptide (no carrier), whereas there was an in-
crease at 2 and 8 weeks in the synthetic peptide and collagen 
group.
DISCUSSION
The purpose of this study was to evaluate the bone regen-
erative effects of the synthetic peptide in a critical-size rat cal-
varial defect model. Eight-millimeter-diameter standardized, 
circular, transosseus defects created on the cranium of rats 
were implanted with synthetic peptide, collagen, or both syn-
thetic peptide and collagen. The healing of each group was 
evaluated histologically and histomorphometrically after 2- 
Table 2. Defect closure (%).
Groups Two weeks Eight weeks
Control 13.9±3.4 15.6±7.2
Collagen alone 22.6±9.3a,b) 26.9±10.4a,c)
Synthetic peptide alone 40.7±1.5d,e) 41.3±9.6a,f)
Synthetic peptide in collagen carrier 45.5±0.9c-e) 52.4±1.4a,b,e)
Group means ± SD, n = 5.
a) Statistically significant difference compared to control group (P < 0.05).
b)  Statistically significant difference compared to newly-formed synthetic peptide 
group (P < 0.01).
c)  Statistically significant difference compared to newly-formed synthetic peptide 
group (P < 0.05).
d) Statistically significant difference compared to control group (P < 0.01).
e) Statistically significant difference compared to collagen group (P < 0.01).
f) Statistically significant difference compared to collagen group (P < 0.05).
Table 3. New bone area (mm2).
Groups Two weeks Eight weeks
Control 0.2±0.2a) 0.3±0.2
Collagen alone 2.9±1.6a,b) 1.9±3.3a,b)
Synthetic peptide alone 3.1±0.5a) 3.0±0.4a)
Synthetic peptide in collagen carrier 3.8±0.7a,b) 4.3±0.9a,c,d)
Group means ± SD, n = 5.
a) Statistically significant difference compared to control group (P < 0.05).
b)  Statistically significant difference compared to newly formed synthetic peptide 
group (P < 0.05).
c) Statistically significant difference compared to collagen group (P < 0.01).
d)  Statistically significant difference compared to newly-formed synthetic peptide 
group (P < 0.01).
Table 4. Bone density (%).
Groups Two weeks Eight weeks
Control 89.6±12.3 92.6±4.9
Collagen alone 12.8±3.0a,b) 86.3±11.9a,c)
Synthetic peptide alone 43.5±13.5a) 43.9±11.8a,b)
Synthetic peptide in collagen carrier 46.6±0.7a,b) 84.4±0.9a,c)
Group means ± SD, n = 5.
a) Statistically significant difference compared to control group (P < 0.05).
b) Statistically significant difference compared to collagen group (P < 0.01).
c)  Statistically significant difference compared to newly-formed synthetic peptide 
group (P < 0.01).
Figure 10. Synthetic peptide in collagen carrier group at 8 weeks 
(H&E stain, ×20) representative photomicrographs of defect sites re-
ceiving synthetic peptide and collagen only at 8 weeks post-surgery. 
At 8 weeks post-surgery, new bone formation was moderate. There 
was loose connective tissue formation around the defect area and 
there was no infiltration of inflammatory cells. Collagen was almost 
resorbed.
NB
Figure 11. Synthetic peptide in collagen carrier group at 8 weeks 
(H&E stain, ×50) representative photomicrographs of defect sites re-
ceiving newly formed synthetic peptide and collagen only at 8 weeks 
post-surgery. There was loose connective tissue formation around 
the defect area and there was no infiltration of inflammatory cells. 
The defect area has been replaced by a parallel pattern of connective 
tissue.
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and 8-week healing intervals.
The critical-size rat calvarial defect used in this study was a 
very convenient model for evaluating bone regenerative ef-
fects of biomaterials. This model is relatively accessible, sim-
ple, and reproducible because spontaneous healing does not 
occur in the control specimen [14]. It has been shown effec-
tive to evaluate the potential for bone formation [15-18]. In 
addition, after bone augmentation, this model has some com-
pressive force, which is similar to intraoral conditions. It has 
many similarities to the maxillofacial region, as anatomically 
the calvaria consists of two cortical plates with a region of in-
tervening cancellous bone similar to the mandible, and phys-
iologically, the cortical bone in the calvaria resembles an atro-
phic mandible. Other advantages are that the observation can 
be focused on the healing process of the bone, since there are 
no major nerves or blood vessels around the rat calvaria and 
that the parameters can be simply and accurately measured 
in each specimen.
The materials that were used were the synthetic peptide and 
collagen. The synthetic peptide has been developed with the 
interest of developing an osteoconductive biomaterial. Based 
on many studies of effective results of BMP-2, the synthetic 
peptide consists of 21 amino acid sequences, with an altera-
tion of just one amino acid sequence from the entire BMP-2 
sequence [19].
The amount of the synthetic peptide used was 10 µL load-
ing (mass, 2,288). This was ten times that of the BMP-2 con-
centration. The amount was set based on the cell test and 100 
times that of the actual concentration is thought to be the best 
concentration. Gel type was used to reduce the volume and 
the ease of use.
In the present study, collagen stabilized the gel type of the 
synthetic peptide, which has a disperse effect. When the syn-
thetic peptide was used with collagen, the effect was enhanced 
and the results were significant when compared with the con-
trol groups or when used with a single biomaterial.
In histometric analysis, the defect closure, new bone area, 
and bone density were compared. The specimen was obtained 
from the middle coronal section. The measurement of length 
of the new bone formation is to compare the amount of cell 
migration. The further the cells migrate, the higher the pos-
sibility of bone union. As the length growth of the cells in-
creases, in considering the thickness, more bone formation 
could be predicted. Therefore, this could be said to be a good 
marker for a membrane’s bone regenerative capacity.
Irrespective of the types of bone graft material used, all de-
fect sites exhibited bone formation in a similar pattern and 
there was more new bone formation at 8 weeks than at base-
line. At 2 weeks, a parallel pattern within was observed and 
newly formed bone without any significant adverse reaction 
was seen. Newly formed bone with osteocytes was evident 
mainly at the periphery of the defects, and osteoblast-like 
cells exhibiting a dense arrangement adjacent to the newly 
formed bone suggest continued bone apposition at the ini-
tial healing stage. However, less bone formative activity was 
found at the central aspects of the defects. Multinucleated 
giant cells were observed in the periphery of the synthetic 
peptide material. There was no evidence of fatty marrow or 
cartilage formation.
At 8 weeks, the quantity of the new bone was greater than 
that observed at 2 weeks and the specimen showed a more 
advanced stage of remodeling and consolidation. The newly 
formed bone consisted of woven bone and lamellar bone, and 
showed cement lines separated earlier from more recently 
deposited bone and concentric rings of the Haversian sys-
tem. However, collagen remnants and dense arrangement 
of osteoblast-like cells were detected at 8 weeks. There was 
no evidence of fatty marrow or cartilage formation.
In tissue engineering technique, the key concept is that an 
isolated cultured cell on a scaffold is transplanted into the tar-
get tissue for its regeneration [20]. Many studies have report-
ed that BMP-2 is effective in bone formation [21] when com-
bined with a carrier, such as collagen or decalcified bone [12-
24]. In the present study, collagen was mostly absorbed, form-
ing new bone. This was more prominent at 8 weeks. No sig-
nificant differences were seen between the time intervals. 2 
and 4 weeks could have been a better comparison. In addi-
tion, the liquid type of synthetic peptide could have been lost 
around the rim for its disparity. This could be changed to gran-
ules or a powder type or could be reinforced with a carrier. 
When used with the synthetic peptide and collagen, the new 
bone formation was enhanced. The concentration could be 
altered through further studies. The experimental group de-
sign and different time interval may have yielded better re-
sults. The synthetic peptide was developed to be effective in 
a minimal gap in osseous defects during implantation. How-
ever, in the present study, a whole defect model was used. 
When embedding this material in implants, it could be pos-
sible to enhance bone formation with a scaffold such as col-
lagen membrane, which would also increase the stability of 
the material [25].
Although the synthetic peptides seem to be effective in peri-
odontal tissue regeneration, they still need further research 
on its suitable sequences and optimal concentration for this 
goal.
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